Showing 891-900 of 3451 results for "".
Of Sharks and Sunscreen
https://practicaldermatology.com/series/scientifically-speaking/of-sharks-and-sunscreen/20130/Often called on to judge "Shark Tank"-style competitions, Humberto Antunes has an eye for what makes an idea work. He talks with host Joel L. Cohen, MD about ingredients for success and also offers insight on sunscreen access in the US.Clinical Conversations: The Data for JAK Inhibitors in AD
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-the-data-for-jak-inhibitors-in-ad/20105/JAK inhibitors represent a new therapeutic class for the treatment of atopic dermatitis. Find out what the data show about their efficacy and tolerability in a conversation between Brad Glick, DO and Raj Chovatiya, MD. Discover how these drugs can fit into the treatment plan and how these experts diPrescribing Biologics: Don't Be Afraid
https://practicaldermatology.com/conferences/aad-summer-2021/prescribing-biologics-dont-be-afraid/19969/Dermatologists have access to a growing armamentarium of safe and effective systemic therapies, but many physicians and patients are still hesitant to use them. Neal Bhatia, MD discusses the importance of prescribing biologics to patients with moderate to severe psoriasis to offer a safe and efficacPower of the Group: Quality of Care in AD
https://practicaldermatology.com/topics/atopic-dermatitis/power-of-the-group-quality-of-care-in-ad/19880/When researchers undertook a survey of eczema centers worldwide, they uncovered common barriers to care and identified potential solutions. Eric Simpson, MD, MCR provides on overview of the Quality of Care in Atopic Dermatitis initiative, with an emphasis on the value of the group-based analysis ofToxin Time: What’s New and Exciting with Neuromodulators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/toxin-time-whats-new-and-exciting-with-neuromodulators/19768/Joel Cohen, MD takes a deep dive into the most recent data on neuromodulators including post-hoc analyses on the potential durability of response. Dr. Cohen also shares updates on Revance’s DAXI, Botox Cosmetic and liquid toxins under development by Galderma and Allergan.Advancing Treatment Parameters in Skin of Color with PicoWay
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advancing-treatment-parameters-in-skin-of-color-with-picoway/19623/Join William Kwan, MD for an overview of advanced treatment guidelines for addressing benign Pigmented Lesions with the PicoWay system. Learn how this picosecond laser has minimized risk relative to Q-switched lasers in the treatment of CALMs, lentigines, and more. New case studies from India and TaTECHtonic Shifts: Big Data, AI, and Dermatology
https://practicaldermatology.com/topics/practice-management/techtonic-shifts-big-data-ai-and-dermatology/18428/Robots can diagnose skin malignancies. Big data may give insurers ammunition to reduce payments. And dermatologists are left dealing with the fall-out from the rapid evolution of technology. In this special edition of Derm Insider Mark Kaufmann, MD dives into the challenges facing the specialty andAchieving Optimal Outcomes with Laser Surgery
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/achieving-optimal-outcomes-with-laser-surgery/18818/Eric Bernstein, MD discusses a variety of laser and light devices and their benefits in treating a myriad of dermatological conditions as well as for cosmetic concerns. He also shares tips for how to use the devices safely to ensure optimal outcomes and to avoid adverse events.Neotensil®: A Novel, Noninvasive Solution That Reduces the Appearance of Under-Eye Bags
https://practicaldermatology.com/topics/practice-management/neotensil-a-novel-noninvasive-solution-that-reduces-the-appearance-of-under-eye-bags/19058/Neotensil is the only noninvasive solution clinically proven to reduce the appearance of under-eye bags within an hour, with benefits that last up to 16 hours. Doris Day, MD, discusses the benefits of Neotensil, as well as patient selection, staff training and how to incorporate this unique and effeDr. Tsao, Dr. Friedlander Recap Biggest Developments for Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/dr-tsao-dr-friedlander-recap-biggest-developments-for-maui-derm/32913/The development of new therapeutics for dermatologic conditions in recent years has been so prolific that Hensin Tsao, MD, PhD, used a “Maui Journal of Medicine” theme for his conference-opening presentation at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.